UnitedHealth Group (UNH) director discloses 13-share dividend award

Rhea-AI Filing Summary

UnitedHealth Group director reports small stock-related award. A UnitedHealth Group Inc. director reported receiving 13 shares of common stock on 12/16/2025 as dividend equivalents on vested deferred stock units, at a stated price of $0. These dividend equivalents vest immediately and follow the same terms as the underlying deferred stock units. After this transaction, the director holds 3,034 UnitedHealth Group shares directly, and additional indirect holdings of 2,146 shares through a revocable trust, 45 shares through one trust, and 55 shares through another trust.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider GARCIA PAUL R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	13	$0.00	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 3,034 shares (Direct); Common Stock — 2,146 shares (Indirect, By Revocable Trust)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GARCIA PAUL R

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MN 55344

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/16/2025		A		13(1)	A	$0	3,034	D
Common Stock								2,146	I	By Revocable Trust
Common Stock								45	I	By Trust 2
Common Stock								55	I	By Trust 3

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Paul R. Garcia	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction at UnitedHealth Group (UNH) is reported here?

A director of UnitedHealth Group Inc. reported receiving 13 shares of common stock on 12/16/2025 as dividend equivalents on vested deferred stock units.

What are the dividend equivalents mentioned in the UnitedHealth (UNH) filing?

The filing states the 13 shares represent dividend equivalents paid on vested deferred stock units, which are immediately vested and subject to the same terms as the underlying deferred stock units.

Did the UnitedHealth Group director pay anything for the new shares?

No. The 13 shares of UnitedHealth Group common stock were reported at a price of $0, reflecting that they were issued as dividend equivalents rather than purchased.

How many UnitedHealth Group (UNH) shares does the director own after this transaction?

After the transaction, the director beneficially owns 3,034 shares directly, and indirectly owns 2,146 shares through a revocable trust, 45 shares through Trust 2, and 55 shares through Trust 3.

What is the relationship of the reporting person to UnitedHealth Group (UNH)?

The reporting person is identified as a Director of UnitedHealth Group Inc. and filed the report as a single reporting person.

Was this UnitedHealth (UNH) insider trade part of a Rule 10b5-1 trading plan?

The form includes a checkbox for trades under a Rule 10b5-1(c) plan, but the provided content does not show that this box was marked as checked for the reported transaction.